Clinical Trial Update: Retinal Ischemia in Central Retinal Vein Occlusion, and the Effects of Treatment With Intravitreal Ranibizumab

View source ↗

Summary

The trial studied retinal ischemia in central retinal vein occlusion and the effects of intravitreal ranibizumab treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Central Retinal Vein Occlusion | Status: COMPLETED